A new Mounjaro user has opened up on their experience taking the drug - including the one side effect they're struggling with ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

Australia's pharmaceuticals watchdog is investigating a spike in adverse event reports for Vyvanse, the country's most ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

The illicit supply of unregulated weight loss drugs is becoming an ‘emerging concern’ for Police Scotland and the.

Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

The FDA granted fast track status to DB-1310, a HER3-targeting antibody-drug conjugate, for advanced nonsquamous non-small ...